Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
Advantech Europe
FLUKE BIOMEDICAL

Noninvasive Alternative to Colonoscopy Wins Partial FDA Approval

By HospiMedica International staff writers
Posted on 18 Feb 2014
Image: The [US] Food and Drug Administration has approved the PillCam Colon for patients who have experienced an incomplete colonoscopy (Photo courtesy of Given Imaging).
Image: The [US] Food and Drug Administration has approved the PillCam Colon for patients who have experienced an incomplete colonoscopy (Photo courtesy of Given Imaging).
A novel-imaging device that is marketed as a noninvasive alternative to colonoscopy has been cleared for use as a tool to screen the large intestine for polyps and other early signs of colon cancer by the US Food and Drug Administration (FDA).

The Given Imaging Ltd. (Yokneam, Israel) PillCam Colon received clearance for sale in Europe (CE marking) in September 2009 and has been commercially available throughout Europe, Latin America, Canada, and parts of Asia.

The Food and Drug Administration has now approved PillCam Colon for patients who have experienced an incomplete colonoscopy. Given Imaging has estimated that approximately 750,000 patients in the US are not able to complete the colonoscopy procedure each year, due to anatomy issues, previous surgery, or various colon diseases.

Analysts estimate that sales of PillCam Colon could grow to over 60 million USD in North America by 2019, with room for expansion as the technology improves.

"Given's management understands that that traditional colonoscopy is the gastroenterologist's bread and butter right now," said MorningStar (Chicago, IL, USA) analyst Debbie Wang. "So they did not want to do anything that would position this as a substitute. Given's PillCam costs USD 500, significantly less than the USD 4,000 for a colonoscopy. Eventually, doctors may use the device to attract adults who avoid regular screenings due to fears of pain, embarrassment, and general discomfort."

The [US] Centers for Disease Control and Prevention's guidelines currently recommend regular colonoscopies beginning at age 50 and continuing until age 75, though the majority of American adults do not follow the recommendations.

Related Links:

Given Imaging Ltd.
MorningStar



Channels

Critical Care

view channel
Image: The Evzio device and trainer (Photo courtesy of kaléo).

“Rescue Pen” Averts Opioid Overdose Risk

A novel autoinjector formulation of naloxone helps reduce the problem of addiction and abuse of prescription opioids. The Evzio pen is modeled on similar devices used deliver epinephrine to patients... Read more

Women's Health

view channel

Low-Dose Aspirin Will Not Prevent Pregnancy Loss

A new study reveals that in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss. Researchers at the University at Buffalo (NY, USA) conducted a placebo-controlled trial that included 1,228 women (aged 18-40 years) who were attempting to become pregnant.... Read more

Business

view channel

Infusion Pumps Propel Global Market Upwards

The global infusion pumps market is expected to grow at a compound annual growth rate (CAGR) of 5.3%, reaching an estimated value of USD 7.8 billion in 2019. These are the latest findings of Transparency Market Research (Albany, NY, USA), a global market intelligence company. Infusion pumps are used to deliver therapeutic... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.